Nathalie Saint‐Jacques

ORCID: 0000-0003-2532-6472
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Colorectal Cancer Screening and Detection
  • Lung Cancer Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • Lung Cancer Treatments and Mutations
  • Heavy Metal Exposure and Toxicity
  • Arsenic contamination and mitigation
  • Acute Lymphoblastic Leukemia research
  • Gastric Cancer Management and Outcomes
  • Spatial and Panel Data Analysis
  • Cancer Risks and Factors
  • Glioma Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Esophageal Cancer Research and Treatment
  • Multiple and Secondary Primary Cancers
  • Health disparities and outcomes
  • Ovarian cancer diagnosis and treatment
  • Breast Cancer Treatment Studies
  • Fish Ecology and Management Studies
  • Nutritional Studies and Diet
  • Radiomics and Machine Learning in Medical Imaging
  • Advances in Oncology and Radiotherapy
  • Childhood Cancer Survivors' Quality of Life
  • Cancer-related molecular mechanisms research
  • Endometrial and Cervical Cancer Treatments

Dalhousie University
2013-2024

Nova Scotia Health Authority
2017-2024

St Joseph's Health Care
2024

Cancer Care Nova Scotia
2008-2024

Public Health Agency of Canada
2022-2024

University of Manitoba
2024

University of Calgary
2022-2024

Canadian Cancer Society
2022-2024

Canadian Partnership Against Cancer
2022-2024

Statistics Canada
2022-2024

<h3>Background:</h3> Regular cancer surveillance is crucial for understanding where progress being made and more must be done. We sought to provide an overview of the expected burden in Canada 2022. <h3>Methods:</h3> obtained data on new incidence from National Cancer Incidence Reporting System (1984–1991) Canadian Registry (1992–2018). Mortality (1984–2019) were Vital Statistics — Death Database. projected mortality counts rates 2022 22 types by sex province or territory. Rates age...

10.1503/cmaj.212097 article EN cc-by-nc-nd Canadian Medical Association Journal 2022-05-01

<h3>Background:</h3> Cancer surveillance data are essential to help understand where gaps exist and progress is being made in cancer control. We sought summarize the expected impact of Canada 2024, with projections new cases deaths from by sex province or territory for all ages combined. <h3>Methods:</h3> obtained on (i.e., incidence, 1984–2019) mortality, 1984–2020) Canadian Registry Vital Statistics Death Database, respectively. projected incidence mortality counts rates 2024 23 types...

10.1503/cmaj.240095 article EN cc-by-nc-nd Canadian Medical Association Journal 2024-05-12

Objectives As part of the International Cancer Benchmarking Partnership (ICBP) SURVMARK-2 project, we provide most recent estimates colon and rectal cancer survival in seven high-income countries by age stage at diagnosis. Methods Data from 386 870 patients diagnosed during 2010–2014 19 registries (Australia, Canada, Denmark, Ireland, New Zealand, Norway UK) were analysed. 1-year 5-year net estimated diagnosis, country, Results (One1-year) varied between (77.1% 87.5%) 59.1% 70.9% (84.8%...

10.1136/gutjnl-2020-320625 article EN Gut 2020-06-01
Naomi Ssenyonga Charles Stiller Kayo Nakata Jaime Shalkow‐Klincovstein S M Redmond and 95 more Jean‐Luc Bulliard Fabio Girardi Christine Fowler Rafael Marcos‐Gragera Audrey Bonaventure Nathalie Saint‐Jacques Pamela Minicozzi Prithwish De Miguel Rodríguez‐Barranco Siri Larønningen V Di Carlo Margit Mägi M. Yu. Vаlkov Karri Seppä Dyfed Huws Michel P. Coleman Claudia Allemani S. Bouzbid M Hamdi-Chérif Rengaswamy Sankaranarayanan Kaouel Meguenni D. Regagba Siné Bayo T Cheick Bougadari Shyam Manraj Karima Bendahhou A Ladipo Olufemi J. Ogunbiyi Nontuthuzelo Somdyala M A Chaplin Florencia Moreno Gladis Calabrano Silvia Espinola B Carballo Quintero Rosalba Fita Walter Laspada Susana Ibañez Carlos Anselmo Lima Allini Mafra da Costa Paulo César De Souza J. Chaves C. Laporte María Paula Curado José Carlos de Oliveira Claudia Veneziano Donaldo Botelho Veneziano Ana Beatriz Almeida Maria do Rosário Dias de Oliveira Latorre Gulnar Azevedo e Silva Marise Souto Rebelo M O Santos J.C. Galaz M Aparicio Aravena J Sanhueza Monsalve D.A. Herrmann Solange Vargas Víctor Herrera Claudia Uribe Luis Eduardo Bravo Luz Stella García Nelson Enrique Arias Ortiz D Morantes Daniel Jurado María Yépez Chamorro Sandra Delgado Melissa Ramirez Yaíma Galán Álvarez Priscila Torres F Martínez-Reyes L. Jaramillo R. Quinto J Castillo Mariela Mendoza Patricia Cueva Jose Cevallos Yepez Bernard Bhakkan Jacqueline Deloumeaux Clarisse Joachim Jonathan Macni R Carrillo Jaime Shalkow Klincovstein Rebeca Rivera-Gómez Patricia Pérez Ebert Poquioma Guillermo Tortolero‐Luna Diego Zavala R. Alonso Enrique Barrios Angela Eckstrand C Nikiforuk Ryan Woods G. Noonan Donna Turner Eshwar Kumar Bin Zhang

BackgroundLeukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed data for children (aged 0–14 years) and adults 15–99 diagnosed with malignancy during 2000–14 in 61 countries. Here, aimed to examine worldwide trends survival from leukaemia, by age morphology, young patients 0–24 years).MethodsWe 258 population-based cancer registries countries participating CONCORD-3 that submitted on leukaemia. We grouped as (0–14 years), adolescents (15–19 (20–24...

10.1016/s2352-4642(22)00095-5 article EN cc-by The Lancet Child & Adolescent Health 2022-04-22
Fabio Girardi M Matz Charles Stiller Hui You Rafael Marcos Gragera and 95 more M. Yu. Vаlkov Jean‐Luc Bulliard Prithwish De David Morrison Miriam Wanner David O’Brian Nathalie Saint‐Jacques Michel P. Coleman Claudia Allemani S. Bouzbid M Hamdi-Chérif Rengaswamy Sankaranarayanan Kaouel Meguenni D. Regagba Saray Mormeneo Bayo T Cheick Bougadari S S Manraj Karima Bendahhou A Ladipo Olufemi J. Ogunbiyi Nontuthuzelo Somdyala M A Chaplin Florencia Moreno G.H. Calabrano S.B. Espinola B Carballo Quintero R Fita W.D. Laspada S.G. Ibañez Carlos Anselmo Lima Allini Mafra da Costa P.C.F. De Souza J. Chaves C. Laporte María Paula Curado J.C. de Oliveira C.L.A. Veneziano Donaldo Botelho Veneziano Ana Beatriz Almeida M R D O Latorre Marise Souto Rebelo M O Santos G Azevedo e Silva J.C. Galaz M Aparicio Aravena J Sanhueza Monsalve D.A. Herrmann S Torres Vargas Víctor Herrera Claudia Uribe Luis Eduardo Bravo Luz Stella García Nelson Enrique Arias Ortiz D Morantes Daniel Jurado María Clara Yépez Chamorro Sandra Delgado Melissa Ramirez Y H Galán Alvarez Priscila Torres F Martínez-Reyes L. Jaramillo R. Quinto J Castillo M Mendoza Patricia Cueva J.G. Yépez Bernard Bhakkan Jacqueline Deloumeaux Clarisse Joachim Jonathan Macni R Carrillo Jaime Shalkow‐Klincovstein Rebeca Rivera-Gómez P Pérez Ebert Poquioma Guillermo Tortolero‐Luna Diego Zavala R. Alonso Enrique Barrios Angela Eckstrand C Nikiforuk Ryan Woods G. Noonan Donna Turner Eshwar Kumar B Zhang Jeff Dowden Gregory P. Doyle Nathalie Saint‐Jacques Gordon Walsh A Anam P De Carol McClure K.A. Vriends

Survival is a key metric of the effectiveness health system in managing cancer. We set out to provide comprehensive examination worldwide variation and trends survival from brain tumors adults, by histology.We analyzed individual data for adults (15-99 years) diagnosed with tumor (ICD-O-3 topography code C71) during 2000-2014, regardless behavior. Data underwent 3-phase quality control as part CONCORD-3. estimated net 11 histology groups, using unbiased nonparametric Pohar Perme...

10.1093/neuonc/noac217 article EN cc-by-nc Neuro-Oncology 2022-11-10

Cancer survival estimates provide insights into the effectiveness of early detection and treatment. The stage cancer at diagnosis is an important determinant survival, reflecting extent spread time disease detection. This work provides stage-specific, five-year results not previously available for Canada.Data reflect population-based Canadian Registry death-linked analytic file covering period from 2010 to 2017. was determined by Collaborative Stage Data Collection System. Five-year net (NS)...

10.25318/82-003-x202300100001-eng article EN PubMed 2023-01-18

Objective To provide the first international comparison of oesophageal and gastric cancer survival by stage at diagnosis histological subtype across high-income countries with similar access to healthcare. Methods As part ICBP SURVMARK-2 project, data from 28 923 patients 25 946 diagnosed during 2012–2014 14 registries in seven (Australia, Canada, Denmark, Ireland, New Zealand, Norway UK) were included. 1-year 3-year age-standardised net estimated diagnosis, (oesophageal adenocarcinoma (OAC)...

10.1136/gutjnl-2021-325266 article EN Gut 2021-11-25

10.1097/jto.0b013e318189f562 article EN publisher-specific-oa Journal of Thoracic Oncology 2008-11-01
Fabio Girardi V Di Carlo Charles Stiller Gemma Gatta Ryan Woods and 95 more Otto Visser Brigitte Lacour T. C. Tucker Michel P. Coleman Claudia Allemani S. Bouzbid M Hamdi-Chérif Rengaswamy Sankaranarayanan Kaouel Meguenni D. Regagba Siné Bayo T Cheick Bougadari S.S. Manraj Karima Bendahhou A Ladipo Olufemi J. Ogunbiyi Nontuthuzelo Somdyala M A Chaplin Florencia Moreno G.H. Calabrano S.B. Espinola B Carballo Quintero R Fita W.D. Laspada S.G. Ibañez Carlos Anselmo Lima Allini Mafra da Costa P.C.F. De Souza J. Chaves C. Laporte María Paula Curado J.C. de Oliveira C.L.A. Veneziano Donaldo Botelho Veneziano Ana Beatriz Almeida M R D O Latorre Marise Souto Rebelo M O Santos G Azevedo e Silva J.C. Galaz M Aparicio Aravena J Sanhueza Monsalve D.A. Herrmann S Torres Vargas Víctor Herrera Claudia Uribe Luis Eduardo Bravo Luz Stella García Nelson Enrique Arias Ortiz D Morantes Daniel Jurado María Clara Yépez Chamorro Sandra Delgado Melissa Ramirez Y H Galán Alvarez Priscila Torres F Martínez-Reyes L. Jaramillo R. Quinto J Castillo M Mendoza Patricia Cueva J.G. Yépez Bernard Bhakkan Jacqueline Deloumeaux Clarisse Joachim Jonathan Macni R Carrillo Jaime Shalkow‐Klincovstein Rebeca Rivera-Gómez P Pérez Ebert Poquioma Guillermo Tortolero‐Luna Diego Zavala R. Alonso Enrique Barrios Angela Eckstrand C Nikiforuk Ryan Woods G. Noonan Donna Turner Eshwar Kumar B Zhang Jeff Dowden Gregory P. Doyle Nathalie Saint‐Jacques Gordon Walsh A Anam P De Carol McClure K.A. Vriends Claude Bertrand Agnihotram V. Ramanakumar Lisa E. Davis Serena Kozie

Abstract Introduction Tumors of the central nervous system are among leading causes cancer-related death in children. Population-based cancer survival reflects overall effectiveness a health care managing cancer. Inequity access to world-wide may result disparities. Methods We considered children (0–14 years) diagnosed with brain tumor during 2000–2014, regardless behavior. Data underwent rigorous, three-phase quality control as part CONCORD-3. implemented revised version International...

10.1093/neuonc/noac232 article EN cc-by-nc Neuro-Oncology 2022-10-10

Measurement of care time intervals is complex, being influenced by many factors. The definition the interval monitored can also bias detection changes in waits. implications using different definitions to report wait times and identify delays provision were examined a retrospective chart review 637 women with surgically treated breast cancer who referred centre between September 1999 2000 or 2003 2004. Overall waits adjuvant treatment increased 12 days over two periods, but their exact...

10.1038/sj.bjc.6603523 article EN cc-by-nc-sa British Journal of Cancer 2006-12-19

Inequalities in health attributable to inequalities society have long been recognized. Typically, those most privileged experience better health, regardless of universal access care. Associations between social and material deprivation mortality from all causes death´ a measure population described for some regions Canada. This study further examines the link focusing on major both rural urban populations. In addition, it quantifies burden premature Canadian setting where care is accessible...

10.1186/s12939-014-0094-2 article EN cc-by International Journal for Equity in Health 2014-10-24

<b>Background:</b> Waiting times for cancer care continue to be an important issue Canadians. We evaluated 2 cohorts of breast patients compare changes in elapsed care, determine the proportion who received their postoperative oncology consultation within recommended time and examine between date surgery start first adjuvant therapy. <b>Methods:</b> conducted a retrospective chart review all women with surgically treated were referred provincial centre The cohort comprised Sept. 1, 1999,...

10.1503/cmaj.060825 article EN cc-by-nc-nd Canadian Medical Association Journal 2007-01-30
Coming Soon ...